Silynxcom (SYNX) Sees Sharp Decline in Trading Session

Silynxcom Ltd (SYNX) closed down 10.46 % during the 24‑hour period ending at 11:12 PM Central Europe on Friday, 23 November 2026. The single share is currently priced at approximately USD 0.74 on major exchanges. With a floating supply of 6.6 million shares, the company’s market capitalisation sits at USD 5.2 million. In the last 24 hours, roughly USD 39.7 k of Silynxcom shares changed hands.

The stock has fallen 28.44 % since the close of the previous month, and its 200‑day simple moving average remains above the current price at USD 1.06. The most recent 52‑week high was USD 1.95, recorded on 3 June 2026, while the 52‑week low reached USD 0.70 on 21 October 2026.

Peer Activity in the Last 24 Hours

  • Neurosense Therapeutics (NRSN) – Up 7.11 %, trading at USD 2.46, with a market capitalisation of USD 4.9 million.
  • Enlivex (ENLV) – Down 9.82 %, now at USD 0.17. Market capitalisation is USD 4 million. Enlivex will enact a 1‑for‑16 reverse share split on 27 October 2026, consolidating ordinary shares from roughly 24.5 million to about 1.5 million and adjusting par value from NIS 6.00 to NIS 96.00.
  • G City (GCT.TA) – Down 0.7 %, priced at ILS 1,132, market capitalisation ILS 599.2 million, P/E ratio 12.08.
  • Tectona (TECT.TA) – Down 0.63 %, trading at ILS 1.44, market capitalisation ILS 12.9 million.
  • Way 2 Vat (W2V.AX) – Flat 0 %, priced at AUD 0.03, market capitalisation AUD 7 million.

Company Overview

Silynxcom Ltd, headquartered in Netanya, Israel, specialises in the development, manufacture, marketing and sale of ruggedised tactical communication headsets and ancillary communication accessories. The devices have undergone rigorous testing and have proven effective in combat environments, securing a global customer base across defence and security sectors.

Outlook

The recent decline in Silynxcom’s share price reflects broader market sentiment and heightened volatility in the defence‑technology sector. However, the company’s core product line remains in high demand, and its global footprint provides a buffer against regional downturns. Investors should monitor the company’s upcoming product launches and potential strategic partnerships, which could stabilise the stock and catalyse a recovery in the near term.